Press Room
The Favored Treatment For Kidney Cancer
05/18/2012
The findings will be presented at the American Urological Association's Annual Meeting, May 19 to 23, in Atlanta.
Gender Comparison In Kidney Cancer Surgery
05/18/2012
Henry Ford Hospital researchers who documented these gender differences can't say why they exist.
Treatment trends, vaccine research, prognosis data
05/18/2012
Mount Sinai School of Medicine researchers will present several landmark studies...
Dover-Sherborn PMC Kids Ride honors Bob Freeman
05/18/2012
Bob never got to ride in the PMC. Shortly after registering, he was diagnosed with kidney cancer and was too sick to ride that summer.
Important progress for people with advanced cancers
05/18/2012
"We have made significant progress for people with advanced cancers in the past year," said Hal Barron M.D.
Drugs Show Strong Responses in Critical Cancers
05/18/2012
Bristol-Myers Squibb's (BMS, US) anti-PD-1 candidate BMS-9936558 is showing promise in several cancers, including renal cell carcinoma (RCC).
What lies ahead: Kaylee's battle with cancer
05/18/2012
An area child battling cancer has more to smile about as she completes her latest course of treatment.
Rosetta Genomics Launches miRview Kidney
05/16/2012
Rosetta Genomics Ltd. (ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced the commercial launch of miRview® kidney, the Company's advanced microRNA assay that uses microRNA expression to classify the four most common kidney tumors: Clear Cell Renal Cell Carcinoma (RCC), Papillary RCC, Chromophobe RCC and Oncocytoma. miRview® kidney will be marketed in the U.S. by Rosetta Genomics' oncology sales team beginning this month.
Kidney Cancer Linked to Gum Disease
05/16/2012
There is a strong link between periodontal disease and kidney cancer, a recent research report in the prestigious journal, Lancet Oncology, confirmed that gum disease increases the risk of kidney cancer by around 50%.
News Feed| Powered by NeonCRM |